Full article: Imiglucerase in the treatment of Gaucher disease: a history and perspective
Progranulin Recruits HSP70 to β-Glucocerebrosidase and Is Therapeutic Against Gaucher Disease - eBioMedicine
PDF) Endocrine and metabolic disorders in patients with Gaucher disease type 1: A review
Downregulation of neurotrophic factors in the brain of a mouse model of Gaucher disease; implications for neuronal loss in Gauch
Partial Restoration of Mutant Enzyme Homeostasis in Three Distinct Lysosomal Storage Disease Cell Lines by Altering Calcium Homeostasis | PLOS Biology
PDF) Clinical manifestations and management of Gaucher disease
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Disruption of morphogenic and growth pathways in lysosomal storage diseases - Corrêa - 2021 - WIREs Mechanisms of Disease - Wiley Online Library
Cells | Free Full-Text | Highlights on Genomics Applications for Lysosomal Storage Diseases
Selective chaperone effect of aminocyclitol derivatives on G202R and other mutant glucocerebrosidases causing Gaucher disease - ScienceDirect
Gaucher disease and Fabry disease: New markers and insights in pathophysiology for two distinct glycosphingolipidoses - ScienceDirect
Gaucher disease: haematological presentations and complications - Thomas - 2014 - British Journal of Haematology - Wiley Online Library
PDF) Alterations in the properties of the cell membrane due to glycosphingolipid accumulation in a model of Gaucher disease
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? - ScienceDirect
IJMS | Free Full-Text | Adipose Tissue Inflammation and Pulmonary Dysfunction in Obesity
Biomolecules | Free Full-Text | Elevated Dkk1 Mediates Downregulation of the Canonical Wnt Pathway and Lysosomal Loss in an iPSC Model of Neuronopathic Gaucher Disease
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Cells | Free Full-Text | GBA, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches
IJMS | Free Full-Text | A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments
Synthesis inhibition therapy for Gaucher disease | Advances in Gaucher Disease: Basic and Clinical Perspectives
Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease | Scientific Reports
IJMS | Free Full-Text | Effects of Intermittent Hypoxia on Cytokine Expression Involved in Insulin Resistance
JCM | Free Full-Text | Glucocerebrosidase: Functions in and Beyond the Lysosome
Cells | Free Full-Text | Novel Molecular Therapies and Genetic Landscape in Selected Rare Diseases with Hematologic Manifestations: A Review of the Literature
A perilous path: the inborn errors of sphingolipid metabolism - Journal of Lipid Research
Frontiers | Emerging Roles of Myeloid-Derived Suppressor Cells in Diabetes
JCM | Free Full-Text | Switching between Enzyme Replacement Therapies and Substrate Reduction Therapies in Patients with Gaucher Disease: Data from the Gaucher Outcome Survey (GOS)
